These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Synthesis and properties of 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as effective antisense oligonucleotides. Morita K; Takagi M; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M Bioorg Med Chem; 2003 May; 11(10):2211-26. PubMed ID: 12713831 [TBL] [Abstract][Full Text] [Related]
35. Oligonucleotides and oligonucleotide conjugates: a new approach for cancer treatment. Da Ros T; Spalluto G; Prato M; Saison-Behmoaras T; Boutorine A; Cacciari B Curr Med Chem; 2005; 12(1):71-88. PubMed ID: 15638731 [TBL] [Abstract][Full Text] [Related]
36. Molecular dynamics simulation and binding energy calculation for estimation of oligonucleotide duplex thermostability in RNA-based therapeutics. Shen L; Johnson TL; Clugston S; Huang H; Butenhof KJ; Stanton RV J Chem Inf Model; 2011 Aug; 51(8):1957-65. PubMed ID: 21702481 [TBL] [Abstract][Full Text] [Related]
37. [Computer aid design of antisense oligonucleotide in gene therapy--review]. Wu QW; Wu JJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):387-91. PubMed ID: 15228675 [TBL] [Abstract][Full Text] [Related]
38. Nucleic acid recognition. Marriage of convenience. Patel DJ Nature; 1993 Oct; 365(6446):490-2. PubMed ID: 8413600 [No Abstract] [Full Text] [Related]
39. Triple helix formation and the antigene strategy for sequence-specific control of gene expression. Praseuth D; Guieysse AL; Hélène C Biochim Biophys Acta; 1999 Dec; 1489(1):181-206. PubMed ID: 10807007 [TBL] [Abstract][Full Text] [Related]